Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession ... apply necessary change with ease, in order to meet patient demand in the rapidly ...

Largest Global Medical Cannabis Company ... Development at Aurora. "It is a testament to our unmatched expertise in navigating international markets that we have the ability to quickly adapt and apply ...

Aurora Cannabis (ACB) has announced today the company’s extended pastille offerings in Australia. This expansion marks another meaningful step ...

Shares of Aurora Cannabis Inc. ACB slipped 4.14% to $5.79 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.07% ...

Aurora Cannabis reported 37% revenue growth in its most recent quarter. The company also posted a profit. The international medical cannabis market has played a key role in its recent rapid growth.

In combination with improved efficiency in the company's manufacturing operations and recent cost reduction initiatives, Aurora's medical cannabis gross margin increased by 600 basis points ...

EDMONTON, AB, February 6, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to announce a ...

Aurora Cannabis Inc. (TSE:ACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports. Three ...

EDMONTON, AB, February 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased ...

Get Our Latest Research Report on Aurora Cannabis Aurora Cannabis Trading Down 3.7 % TSE:ACB opened at C$8.63 on Friday. The stock’s 50 day moving average price is C$6.08 and its 200 day moving ...